Insitro vs FORE Biotherapeutics
Insitro vs FORE Biotherapeutics, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Insitro is on 62/100 and FORE Biotherapeutics on 56/100.
Where each one leads
Insitro
- our overall score: 62/100 against 56/100
- domain rating: 64/100 against 33/100
- headcount: 255 against 56
- headcount growth: +10.9% against +8.2%
- LinkedIn following: 42,173 against 4,584
FORE Biotherapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Insitro | FORE Biotherapeutics |
|---|---|---|
| What it is | Data-driven drug discovery and development company using machine learning and high-throughput biology. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, Drug Discovery, Drug Development, DNA | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2011 |
| Headquarters | South San Francisco, United States | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Insitro | FORE Biotherapeutics |
|---|---|---|
| Employees | 255 | 56 |
| Headcount growthLast 12 months | +10.9% | +8.2% |
| Total funding | $243M | $232M |
| Latest round | Series B | Series D-2 Extension |
| Valuation | $7.0B | $75.0M |
| LinkedIn followers | 42,173 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Insitro | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 56/100 |
| Traction | 60/100 | 58/100 |
| Team | 50/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 62/100 | 38/100 |
| Quality | 65/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 64/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Insitro | FORE Biotherapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
Insitro vs FORE Biotherapeutics: common questions
Which is better, Insitro or FORE Biotherapeutics?
On our 0-100 score Insitro rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Insitro and FORE Biotherapeutics compare on the numbers?
Insitro leads on our overall score (62/100 against 56/100), domain rating (64/100 against 33/100), headcount (255 against 56), headcount growth (+10.9% against +8.2%), LinkedIn following (42,173 against 4,584).
Read the full Insitro review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Insitro alternatives we track.